Search - tctmd.com

Displaying 81 - 100 of 131

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Daily News

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

Todd Neale

December 20, 2015

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Daily News

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Yael L. Maxwell

March 24, 2015

Advertisement

TCTMD’s Top 10 Most Popular Stories for July 2016

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

DES, BMS Both Suitable for Treating Patients With SVG Lesions

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content